Bioequivalence Study of Rivaroxaban 20 mg Film-coated Tablets
NCT06558045
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Rivaroxaban 20 mg film-coated tablet
DRUG:
Xarelto 20 mg film-coated tablet
Sponsor
Dexa Medica Group